Long-term Safety of Topical Pimecrolimus and Topical Tacrolimus in Atopic Blepharoconjunctivitis

被引：8
|
作者：
Kiiski, Ville [1 ]
Remitz, Anita [1 ]
Reitamo, Sakari [1 ]
Mandelin, Johanna [1 ]
Kari, Osmo [1 ]
机构：
[1] Univ Helsinki, Cent Hosp, Skin & Allergy Hosp, Helsinki 00250, Finland
来源：
JAMA DERMATOLOGY | 2014年 / 150卷 / 05期
关键词：
OINTMENT; DERMATITIS;
D O I：
10.1001/jamadermatol.2013.7016
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：571 / 573
页数：3
相关论文
共 50 条
  • [1] Treatment of Refractory Atopic Blepharoconjunctivitis with Topical Tacrolimus 0.03% Dermatologic Ointment
    Sakarya, Yasar
    Sakarya, Rabia
    [J]. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 28 (01) : 94 - 96
  • [2] LONG-TERM SAFETY OF CRISABOROLE TOPICAL OINTMENT, 2%, IN ATOPIC DERMATITIS
    Eichenfield, L.
    Call, R.
    Forsha, D.
    Fowler, J.
    Hebert, A.
    Spellman, M.
    Gold, L. Stein
    Van Syoc, M.
    Zane, L.
    Tschen, E.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S21 - S21
  • [3] Long-term safety of crisaborole topical ointment, 2%, in atopic dermatitis
    Eichenfield, L.
    Call, R. S.
    Forsha, D.
    Fowler, J.
    Hebert, A. A.
    Spellman, M.
    Gold, L. F. Stein
    Van Syoc, M.
    Zane, L. T.
    Tschen, E. H.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S49 - S49
  • [4] TOPICAL PIMECROLIMUS AND TACROLIMUS AND THE RISK OF CANCER
    Sanchez-Perez, J.
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2007, 98 (05): : 312 - 317
  • [5] Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug
    Kapp, A
    Papp, K
    Bingham, A
    Fölster-Holst, R
    Ortonne, JP
    Potter, PC
    Gulliver, W
    Paul, C
    Molloy, S
    Barbier, N
    Thurston, M
    de Prost, Y
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 110 (02) : 277 - 284
  • [6] Topical tacrolimus and pimecrolimus: Future directions
    Ling, MR
    [J]. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2001, 20 (04) : 268 - 274
  • [7] The topical calcineurin inhibitor pimecrolimus in atopic dermatitis: a safety update
    Thaci, D.
    Salgo, R.
    [J]. ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, 2007, 16 (02): : 58 - 62
  • [8] Topical use of pimecrolimus in atopic dermatitis: Update on the safety and efficacy
    Werfel, Thomas
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 (09): : 739 - 743
  • [9] Spotlight on topical pimecrolimus in atopic dermatitis
    Wellington K.
    Jarvis B.
    [J]. American Journal of Clinical Dermatology, 2002, 3 (6) : 435 - 438
  • [10] Topical tacrolimus and pimecrolimus are not associated with skin atrophy
    Bos, JD
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 (02) : 342 - 342
12345